FibroBiologics Inc. Common Stock
FBLG | NASDAQ
$1.38
+$0.02 (+1.47%)
Sep 22, 2026, 12:41 PM ET · Market open
Fiscal Year Period Ending | FY 2025 Dec 30, 2025 | FY 2024 Dec 30, 2024 | FY 2023 Dec 30, 2023 | FY 2022 Dec 30, 2022 | FY 2021 Dec 30, 2021 | FY 2020 Dec 30, 2020 |
|---|---|---|---|---|---|---|
Revenue | n/a | n/a | n/a | n/a | n/a | n/a |
Cost of Revenue | 832K | n/a | n/a | n/a | n/a | n/a |
Gross Profit | -832K | n/a | n/a | n/a | n/a | n/a |
Operating Income | -16.65M | -13.74M | -8.89M | -4.47M | -1.58M | -1.17M |
Interest Income | 247K | 251K | n/a | n/a | n/a | n/a |
Pretax Income | -18.65M | -11.16M | -16.49M | -5.12M | -1.58M | -1.17M |
Net Income | -18.65M | -11.16M | -16.49M | -5.12M | -1.58M | -1.17M |
Selling & General & Admin | 9.24M | 9.23M | 6.52M | 3.32M | 1.06M | 500K |
Research & Development | 7.41M | 4.5M | 2.37M | 1.15M | 521K | 669K |
Other Expenses | -832K | n/a | n/a | n/a | n/a | n/a |
Operating Expenses | 15.82M | 13.74M | 8.89M | 4.47M | 1.58M | 1.17M |
Interest Expense | 204K | 20K | 147K | 654K | 4K | n/a |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 16.65M | 13.74M | 8.89M | 4.47M | 1.58M | 1.17M |
Income Tax Expense | n/a | n/a | n/a | n/a | n/a | n/a |
Shares Outstanding (Basic) | 2.23M | 1.64M | 1.62M | 1.62M | 1.62M | 1.62M |
Shares Outstanding (Diluted) | 2.23M | 1.64M | 1.62M | 1.62M | 1.62M | 1.62M |
EPS (Basic) | -8.40 | -6.80 | -11.80 | -3.20 | -0.97 | -0.72 |
EPS (Diluted) | -8.40 | -6.80 | -11.80 | -3.20 | -0.97 | -0.72 |
EBITDA | -17.61M | -10.57M | -15.9M | -4.37M | -1.58M | n/a |
EBIT | -18.44M | -11.14M | -16.34M | -4.47M | -1.58M | -1.17M |
Depreciation & Amortization | 832K | 573K | 437K | 94K | n/a | 1.17M |
Add to Watchlist
Select watchlists to add or remove FBLG